QbD Group
    Request auditContact us
    Explore services by industry
    Elemental Impurities Reports – Comprehensive risk assessments for pharmaceutical compliance

    Elemental Impurities Reports

    Comprehensive risk assessments for pharmaceutical compliance

    QbD Group provides comprehensive risk assessments and reports for elemental impurities in human and veterinary pharmaceutical products, ensuring compliance with ICH Q3D guidelines and regulatory requirements.

    What is Elemental Impurities Risk Assessment?

    Ensuring compliance with elemental impurities regulations starts with a thorough risk assessment of your pharmaceutical manufacturing processes. At QbD Group, we guide you through the four essential steps of risk assessment:

    1. Identifying potential sources of elemental impurities.
    2. Analyzing the elements introduced by each contamination source.
    3. Evaluating actual or predicted levels against established PDE values.
    4. Defining a control strategy based on the results.

    Our expert team ensures a comprehensive approach to help you meet regulatory standards while safeguarding product quality and patient safety.

    Elemental Impurities Reports — QbD Group

    Why control of elemental impurities matters

    Elemental impurities offer no therapeutic benefit and must be controlled within acceptable limits, as outlined in ICH Q3D guidelines.

    Regulatory requirement

    Mandatory for Marketing Authorization Applications (MAA) and GMP inspections.

    Patient safety

    Controlling impurities protects patients from potential health risks.

    Audit readiness

    Documented risk assessments are mandatory for audits and inspections.

    Registration dossiers

    Reports must be included in regulatory submissions.

    From consultation to compliance: our step-by-step process

    Our structured approach ensures a seamless and compliant evaluation of elemental impurities in your drug products.

    1. Initial consultation

    Understand your specific needs and regulatory concerns to tailor our approach.

    2. Data collection

    Gather documentation including manufacturing process details and manufacturer statements.

    3. Risk assessment report

    Detailed report identifying contamination sources and assessing risks per EMA/FDA guidelines.

    4. Report delivery

    Comprehensive report with impurity levels, PDE comparisons, and control recommendations.

    5. Follow-up support

    Ongoing assistance including acceptable limit calculations and detection limit recommendations.

    Elemental Impurities Process — QbD Group
    QbD Group expertise

    Why QbD Group

    Your trusted partner

    Our EUROTOX-certified team ensures the highest standards of scientific quality and regulatory reliability in every elemental impurities assessment.

    End-to-end toxicology support

    from early development to post-approval changes.

    Trusted expertise at scale

    decades of combined experience across diverse projects.

    Proactive compliance monitoring

    staying ahead of evolving regulations.

    Certified Toxicology Experts

    EUROTOX-certified (ERT) toxicologists on every project.

    Let's talk Toxicology

    From risk assessments to regulatory compliance, our toxicology experts are ready to support your pharmaceutical needs.